SP
EXAS

Symmetry Partners’s Exact Sciences EXAS Stock Holding History

Symmetry Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,994
Closed -$207K – 526
2024
Q1 		$207K Hold
2,994
– – 0.02% 524
2023
Q4 		$227K Buy
+2,994
New +$196K 0.01% 462
2021
Q3 		– Sell
-2,043
Closed -$254K – 651
2021
Q2 		$254K Hold
2,043
– – 0.02% 604
2021
Q1 		$269K Hold
2,043
– – 0.02% 574
2020
Q4 		$271K Hold
2,043
– – 0.02% 541
2020
Q3 		$208K Buy
+2,043
New +$176K 0.02% 561
2019
Q4 		– Sell
-2,787
Closed -$252K – 339
2019
Q3 		$252K Hold
2,787
– – 0.05% 277
2019
Q2 		$329K Buy
+2,787
New +$281K 0.07% 231

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Symmetry Partners's EXAS Position: Q2 2024 in Review

Symmetry Partners sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 2,994 shares — an estimated $207K sold.

Symmetry Partners first reported a position in EXAS in Q2 2019 and held it in 8 quarters. The position peaked at $329K in Q2 2019. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Symmetry Partners reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Symmetry Partners sold 2,994 Exact Sciences shares in Q2 2024, an estimated $207K.
  • Symmetry Partners first reported a position in Exact Sciences in Q2 2019 and held it in 8 quarters.
  • Symmetry Partners's Exact Sciences position peaked at $329K in Q2 2019.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Symmetry Partners's 13F filing for Q2 2024, filed 11 Jul 2024.